Haute Capital Partners Valuation Multiples
Discover Haute Capital Partners' revenue and EBITDA valuation multiples and investment history.
Haute Capital Partners Overview
About Haute Capital Partners
Haute Capital Partners AG is a Swiss investment firm catering to both institutional and individual investors. It offers investment solutions across private equity, real estate, and public markets. In Private Equity, the company identifies and supports businesses with growth potential, offering its investors access to opportunities with upside potential and resilience in all economic conditions; the Real Estate division focuses on acquiring and managing assets that provide stability and consistent cash flow; and the Public Markets division optimizes portfolios of listed assets, including equities, ETFs, and crypto-assets. The company classifies its business into three segments: securities, which generate maximum revenue, real estate, and others.
Founded
2017
HQ
Employees
10
Website
Financials (FY)
EV
$64M
Valuation Multiples
Start free trial
Haute Capital Partners Financials
Haute Capital Partners reported last fiscal year revenue of $1M and negative EBITDA of ($5M).
In the same fiscal year, Haute Capital Partners generated ($963K) in gross profit, ($5M) in EBITDA losses, and had net loss of ($5M).
Haute Capital Partners P&L
In the most recent fiscal year, Haute Capital Partners reported revenue of $1M and EBITDA of ($5M).
Haute Capital Partners is unprofitable as of last fiscal year, with gross margin of (83%), EBITDA margin of (394%), and net margin of (473%).
Financial data powered by Morningstar, Inc.
Haute Capital Partners Stock Performance
Haute Capital Partners has current market cap of $80M, and enterprise value of $64M.
Haute Capital Partners' stock price is $63.98.
Haute Capital Partners has an EPS (earnings per share) of $-4.39.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $64M | $80M | 2.2% | - | - | - | $-4.39 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHaute Capital Partners Valuation Multiples
Haute Capital Partners trades at 55.5x EV/Revenue multiple, and (14.1x) EV/EBITDA.
Haute Capital Partners Financial Valuation Multiples
As of July 16, 2026, Haute Capital Partners has market cap of $80M and EV of $64M.
Haute Capital Partners has a P/E ratio of (14.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Haute Capital Partners Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Haute Capital Partners Margins & Growth Rates
In the most recent fiscal year, Haute Capital Partners reported gross margin of (83%), EBITDA margin of (394%), and net margin of (473%).
Haute Capital Partners Margins
Haute Capital Partners Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Haute Capital Partners Operational KPIs
Haute Capital Partners' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.4M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Haute Capital Partners Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Haute Capital Partners competitors and their valuation data. Start Free Trial | ||||||
Investments by Haute Capital Partners
Haute Capital Partners has invested in 2 companies to date.
Latest investment by Haute Capital Partners was on July 9th 2026. Haute Capital Partners invested in Exentis in their Secondary round.
Latest Investments by Haute Capital Partners
| Description | Exentis is a company that produces equipment and materials supporting three-dimensional screen printing applications. | BioCopy is a Munich-based biotech developing molecular printing technology to amplify DNA and proteins via enzymatic replication on chips. Its platform copies 10^9 molecules in 30 minutes without PCR, used for diagnostics and synthetic biology. Patented in 2005, it targets point-of-care testing. |
| HQ Country |  | |
| HQ City | Stetten | Freiburg |
| Deal Date | 9 Jul 2026 | 12 Mar 2026 |
| Round | Secondary | Series A |
| Raised | undisclosed | $600K |
| Investors | Haute Capital Partners | Haute Capital Partners |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Haute Capital Partners investments and their VC round multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Haute Capital Partners
| When was Haute Capital Partners founded? | Haute Capital Partners was founded in 2017. |
| Where is Haute Capital Partners headquartered? | Haute Capital Partners is headquartered in Switzerland. |
| How many employees does Haute Capital Partners have? | As of today, Haute Capital Partners has over 10 employees. |
| Is Haute Capital Partners publicly listed? | Yes, Haute Capital Partners is a public company listed on Düsseldorf Stock Exchange. |
| What is the stock symbol of Haute Capital Partners? | Haute Capital Partners trades under W76 ticker. |
| When did Haute Capital Partners go public? | Haute Capital Partners went public in 2025. |
| Who are competitors of Haute Capital Partners? | Haute Capital Partners main competitors include |
| What is the current market cap of Haute Capital Partners? | Haute Capital Partners' current market cap is $80M. |
| What is the current revenue of Haute Capital Partners? | Haute Capital Partners' last fiscal year revenue is $1M. |
| What is the current EV/Revenue multiple of Haute Capital Partners? | Current revenue multiple of Haute Capital Partners is 55.5x. |
| Is Haute Capital Partners profitable? | No, Haute Capital Partners is not profitable. |
| How many companies Haute Capital Partners has acquired to date? | Haute Capital Partners hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Haute Capital Partners has invested to date? | As of July 2026, Haute Capital Partners has invested in 2 companies. |
| What was the last Haute Capital Partners investment? | On 9th July 2026 Haute Capital Partners invested in Exentis, participating in a Secondary round. |
| In what companies Haute Capital Partners invested in? | Haute Capital Partners invested in BioCopy and Exentis. |
Lists including Haute Capital Partners
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.